Literature DB >> 10447763

Enterobacterial infection modulates major histocompatibility complex class I expression on mononuclear cells.

J Kirveskari1, Q He, M Leirisalo-Repo, O Mäki-Ikola, M Wuorela, A Putto-Laurila, K Granfors.   

Abstract

Major histocompatibility complex (MHC) class I expression is reduced in several viral infections, but it is not known whether the same happens during infections caused by intracellular enterobacteria. In this study, the expression of MHC class I antigens on peripheral blood mononuclear cells (PBMC) from 16 patients with Salmonella, Yersinia, or Klebsiella infection was investigated. During or after the acute infection, the expression of MHC class I antigens was markedly decreased in eight patients, all with genotype HLA-B27, and six out of eight with reactive arthritis (ReA). A significant decrease of monomorphic MHC class I was found in three patients, of HLA-B27 in eight (P<0.05) and of HLA-A2 in two. However, patients negative for the HLA-B27 genotype, or healthy HLA-B27-positive individuals, did not have a significant decrease of MHC class I antigens. During the decreased expression on the cell surface, intracellular retention of MHC class I antigens was observed, whereas HLA-B27 mRNA levels did not vary significantly. This is the first evidence that enterobacterial infection may down-regulate expression of MHC class I molecules in vivo and that down-regulation is predominant in patients with the HLA-B27 genotype.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447763      PMCID: PMC2326857          DOI: 10.1046/j.1365-2567.1999.00803.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  Molecular typing of HLA-B27 alleles.

Authors:  O Dominguez; E Coto; E Martinez-Naves; S Y Choo; C López-Larrea
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  HLA-B27 expression modulates gram-negative bacterial invasion into transfected L cells.

Authors:  K Kapasi; R D Inman
Journal:  J Immunol       Date:  1992-06-01       Impact factor: 5.422

3.  Failure of the serological determination of HLA-B27 due to antigen masking in patients with ankylosing spondylitis.

Authors:  J Neumüller; M Fischer; R Eberl
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

4.  A monoclonal antibody that recognizes HLA-B27 in the context of peptides.

Authors:  J Wang; D T Yu; T Fukazawa; H Kellner; J Wen; X K Cheng; G Roth; K M Williams; R B Raybourne
Journal:  J Immunol       Date:  1994-02-01       Impact factor: 5.422

5.  Transient loss of HLA B27.

Authors:  B Amor; A Kahan; A E Georgiadis
Journal:  Lancet       Date:  1978-02-04       Impact factor: 79.321

6.  Serological diagnosis of salmonella infections by enzyme immunoassay.

Authors:  O Isomäki; R Vuento; K Granfors
Journal:  Lancet       Date:  1989-06-24       Impact factor: 79.321

7.  Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis.

Authors:  H Repo; M Jäättelä; M Leirisalo-Repo; M Hurme
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

8.  Alteration of HLA-B27 peptide presentation after infection of transfected murine L cells by Shigella flexneri.

Authors:  F Boisgérault; J Mounier; V Tieng; M C Stolzenberg; I Khalil-Daher; M Schmid; P Sansonetti; D Charron; A Toubert
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Yersinia lipopolysaccharide is modified by human monocytes.

Authors:  M Wuorela; S Jalkanen; P Toivanen; K Granfors
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

10.  Genetic modulation of antigen presentation by HLA-B27 molecules.

Authors:  L Pazmany; S Rowland-Jones; S Huet; A Hill; J Sutton; R Murray; J Brooks; A McMichael
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Endosomal processing for antigen presentation mediated by CD1 and Class I major histocompatibility complex: roads to display or destruction.

Authors:  Marianne Boes; Arie J Stoppelenburg; Fenna C M Sillé
Journal:  Immunology       Date:  2009-06       Impact factor: 7.397

2.  Streptokinase promotes development of dipeptidyl peptidase IV (CD26) autoantibodies after fibrinolytic therapy in myocardial infarction patients.

Authors:  Miguel Cuchacovich; Héctor Gatica; Paula Vial; Jorge Yovanovich; Salvatore V Pizzo; Mario Gonzalez-Gronow
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

Review 3.  Insights into the Role of Infection in the Spondyloarthropathies.

Authors:  Y Liu; M A Penttinen; K Granfors
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

Review 4.  The role of infection in the pathogenesis of spondyloarthropathies with special reference to human leukocyte antigen-B27.

Authors:  Markus A Penttinen; Yi Liu; Kaisa Granfors
Journal:  Curr Rheumatol Rep       Date:  2002-12       Impact factor: 4.592

5.  Impairment of intramacrophagic Brucella suis multiplication by human natural killer cells through a contact-dependent mechanism.

Authors:  Jacques Dornand; Virginie Lafont; Jane Oliaro; Annie Terraza; Elsa Castaneda-Roldan; Jean-Pierre Liautard
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

Review 6.  Microbes as Master Immunomodulators: Immunopathology, Cancer and Personalized Immunotherapies.

Authors:  Joana R Lérias; Georgia Paraschoudi; Eric de Sousa; João Martins; Carolina Condeço; Nuno Figueiredo; Carlos Carvalho; Ernest Dodoo; Mireia Castillo-Martin; Antonio Beltrán; Dário Ligeiro; Martin Rao; Alimuddin Zumla; Markus Maeurer
Journal:  Front Cell Dev Biol       Date:  2020-01-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.